A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

Active, not recruitingOBSERVATIONAL

Enrollment

180

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions

Systemic Lupus ErythematosusTelitaciceptBelimumabEfficacy and Safety

Trial Locations (1)

Qianfoshan Hospital, Jinan

All Listed Sponsors

collaborator

Renmin Hospital of Wuhan University

OTHER

collaborator

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

OTHER

collaborator

Beijing Friendship Hospital

OTHER

lead

Yipeng Liu

OTHER